Procter & Gamble Company (The) $PG Stock Purchased by Soltis Investment Advisors LLC

Key Points

• Soltis Investment Advisors increased its Procter & Gamble stake by 39.6% in the third quarter, bringing its holdings to 89,378 shares valued at approximately $13.0 million. Institutional investors collectively own 65.77% of PG.
• P&G exceeded quarterly expectations, reporting $2.00 in adjusted earnings per share and $23.28 billion in revenue, up 4% year over year. Analysts maintain a “Moderate Buy” consensus rating with an average price target of $170.57.
• The company declared a quarterly dividend of $1.0885, equivalent to an annualized $4.35 payout and a 2.7% yield. Meanwhile, insiders sold $9.27 million worth of shares over the past 90 days, and rising costs remain a potential margin pressure.

Soltis Investment Advisors LLC boosted its position in Procter & Gamble Company (The) (NYSE:PG - Free Report) by 39.6% in the third quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 89,378 shares of the company's stock after purchasing an additional 25,339 shares during the period. Procter & Gamble comprises approximately 0.6% of Soltis Investment Advisors LLC's holdings, making the stock its 29th largest position. Soltis Investment Advisors LLC's holdings in Procter & Gamble were worth $12,985,000 at the end of the most recent quarter.

Other institutional investors also recently added to or reduced their stakes in the company. Mowery & Schoenfeld Wealth Management LLC purchased a new position in shares of Procter & Gamble during the 2nd quarter worth approximately $26,000. Montgomery Financial Services LLC acquired a new stake in shares of Procter & Gamble in the 2nd quarter valued at approximately $28,000. Paladin Partners LLC acquired a new stake in shares of Procter & Gamble in the 2nd quarter valued at approximately $29,000. Toews Corp ADV purchased a new stake in shares of Procter & Gamble in the second quarter valued at approximately $37,000. Finally, Evergreen Advisors LLC purchased a new stake in shares of Procter & Gamble in the first quarter valued at approximately $37,000. Hedge funds and other institutional investors own 65.77% of the company's stock.

Insider Transactions at Procter & Gamble

In other Procter & Gamble news, CEO Paul Gama sold 4,331 shares of the company's stock in a transaction dated Friday, October 23rd. The shares were sold at an average price of $161.27, for a total value of $698,460.37. Following the sale, the chief executive officer owned 46,793 shares of the company's stock, valued at $7,546,307.11. This represents a 8.47% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, CEO Shailesh Jejurikar sold 35,000 shares of the company's stock in a transaction dated Friday, October 23rd. The shares were sold at an average price of $163.09, for a total transaction of $5,708,150.00. Following the completion of the sale, the chief executive officer directly owned 55,391 shares in the company, valued at $9,033,718.19. This trade represents a 38.72% decrease in their position. The SEC filing for this sale provides additional information. Insiders sold 58,647 shares of company stock worth $9,268,508 in the last 90 days. Insiders own 0.23% of the company's stock.

Procter & Gamble Price Performance

Shares of NYSE:PG opened at $160.48 on Friday. The business's 50 day simple moving average is $149.62 and its 200-day simple moving average is $148.85. The firm has a market capitalization of $371.95 billion, a price-to-earnings ratio of 24.17, a price-to-earnings-growth ratio of 3.89 and a beta of 0.39. The company has a debt-to-equity ratio of 0.40, a current ratio of 0.72 and a quick ratio of 0.53. Procter & Gamble Company has a 12 month low of $137.62 and a 12 month high of $167.25.

Procter & Gamble (NYSE:PG - Get Free Report) last released its quarterly earnings results on Thursday, October 22nd. The company reported $2.00 earnings per share for the quarter, topping analysts' consensus estimates of $1.89 by $0.11. Procter & Gamble had a return on equity of 31.02% and a net margin of 18.23%. The business had revenue of $23.28 billion for the quarter, compared to analysts' expectations of $22.80 billion. During the same quarter in the prior year, the firm posted $1.99 EPS. The company's revenue was up 4.0% compared to the same quarter last year. As a group, equities analysts forecast that Procter & Gamble Company will post 6.99 earnings per share for the current fiscal year.

Procter & Gamble Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Monday, November 16th. Investors of record on Friday, October 23rd will be paid a $1.0885 dividend. This represents a $4.35 dividend on an annualized basis and a yield of 2.7%. The ex-dividend date of this dividend is Friday, October 23rd. Procter & Gamble's dividend payout ratio is presently 65.51%.

Key Procter & Gamble News

Here are the key news stories impacting Procter & Gamble this week:

• Positive Sentiment: Quarterly beat supports the stock: P&G reported earnings of $2.00 per share versus the $1.89 consensus estimate, while revenue of $23.28 billion exceeded expectations. Sales increased 4% year over year, helping reinforce confidence in the company’s growth outlook. What Did Procter & Gamble's Latest Quarter Change for Its Stock?
• Positive Sentiment: Analyst upgrade adds support: Freedom Broker raised its rating on PG from “hold” to “buy,” signaling increased confidence in the company’s earnings durability and valuation potential. Freedom Broker upgrades Procter & Gamble to buy from hold
• Positive Sentiment: Revenue growth and dividend appeal remain key attractions: Organic sales rose 4%, with much of the gain coming from higher product volumes. P&G’s portfolio of leading brands and long dividend history continue to appeal to income-focused investors. Procter & Gamble is Accelerating Revenue Growth as its Costs are Rising
• Neutral Sentiment: New bond issuance highlights financing strategy: P&G tapped euro and dollar markets with fixed-rate notes, providing funding flexibility but also adding debt obligations. The issuance puts greater focus on the company’s balance sheet and already elevated valuation. Procter & Gamble Bond Sale Puts Its Pricey Valuation Narrative In Focus
• Negative Sentiment: Cost inflation and mixed ratings temper optimism: Rising commodity and operating costs could pressure margins, while DZ Bank downgraded PG from “strong-buy” to “hold.” ETF net selling also represents a modest technical headwind. How Is Procter & Gamble Handling Commodity Costs After Its Report?

Analysts Set New Price Targets

PG has been the subject of several research analyst reports. UBS Group set a $166.00 price objective on Procter & Gamble in a research report on Friday, October 23rd. Bank of America decreased their target price on shares of Procter & Gamble from $170.00 to $166.00 and set a "buy" rating on the stock in a research report on Friday, July 10th. Deutsche Bank Aktiengesellschaft reaffirmed a "buy" rating on shares of Procter & Gamble in a research note on Friday, October 23rd. Freedom Broker upgraded shares of Procter & Gamble from a "hold" rating to a "buy" rating and set a $176.00 price target for the company in a report on Friday, October 23rd. Finally, Wells Fargo & Company increased their price target on shares of Procter & Gamble from $164.00 to $180.00 and gave the company an "overweight" rating in a report on Friday, October 23rd. Fifteen analysts have rated the stock with a Buy rating and eleven have issued a Hold rating to the stock. According to MarketBeat, Procter & Gamble presently has a consensus rating of "Moderate Buy" and a consensus target price of $170.57.

About Procter & Gamble

Procter & Gamble Company NYSE: PG is a global consumer products company that develops, manufactures and markets branded products used in households and personal care. Its portfolio includes personal health and grooming products, beauty and skin care items, baby, feminine and family care products, fabric and home care products, and oral care products.

The company's well-known brands include Pampers, Tide, Gillette, Crest, Oral-B, Head & Shoulders, Pantene, Olay, Old Spice, Dawn, Febreze and Mr.

Want to see what other hedge funds are holding PG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Procter & Gamble Company (The) (NYSE:PG - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.